Scarica l'app Stockscreener
2.70
3.05%
0.08
Dopo l'orario di chiusura:
2.75
0.05
+1.85%
Immix Biopharma Inc Borsa (IMMX) Ultime notizie
Is Immix Biopharma Inc. still worth holding after the dipGap Up & Stepwise Entry and Exit Trade Signals - newser.com
Risk adjusted return profile for Immix Biopharma Inc. analyzedOptions Play & Fast Gain Stock Trading Tips - newser.com
How to monitor Immix Biopharma Inc. with trend dashboardsWeekly Market Report & Daily Profit Maximizing Trade Tips - newser.com
Will Immix Biopharma Inc. benefit from macro trends2025 Bull vs Bear & Growth Focused Entry Point Reports - newser.com
Is Immix Biopharma Inc. stock poised for growth2025 Stock Rankings & Precise Swing Trade Entry Alerts - newser.com
How to integrate Immix Biopharma Inc. into portfolio analysis toolsWeekly Trend Report & Smart Money Movement Alerts - newser.com
Is Immix Biopharma Inc. reversing from oversold territoryCPI Data & Weekly Setup with High ROI Potential - newser.com
Immix Biopharma to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference - The Manila Times
Immix Biopharma, Inc. to Present at Guggenheim Healthcare Innovation Conference on November 11, 2025 - Quiver Quantitative
Nov 11 Fireside Chat 12:30 ET — Immix Biopharma to Present at Guggenheim Healthcare Conference - Stock Titan
Why Immix Biopharma Inc. stock could benefit from AI revolution2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - newser.com
Using AI based signals to follow Immix Biopharma Inc.2025 Price Targets & Low Risk Entry Point Tips - newser.com
What analysts say about Immix Biopharma Inc stockSector-Based Investing & Low Cost Wealth Strategies - earlytimes.in
Using flow based indicators on Immix Biopharma Inc.July 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - newser.com
Published on: 2025-10-10 06:23:37 - newser.com
Multi factor analysis applied to Immix Biopharma Inc.July 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
Analyzing drawdowns of Immix Biopharma Inc. with statistical tools2025 Volume Leaders & AI Driven Stock Movement Reports - newser.com
Will Immix Biopharma Inc. stock outperform growth indexesWall Street Watch & Reliable Intraday Trade Alerts - newser.com
Immix Biopharma's (IMMX) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Comparing Immix Biopharma (NASDAQ:IMMX) & Candel Therapeutics (NASDAQ:CADL) - Defense World
Is Immix Biopharma Inc a good long term investmentLong-Term Investment Plans & Exceptional Profit Trading - earlytimes.in
Immix Biopharma to Present Abstract at the upcoming ASH 2025 Annual Meeting - GlobeNewswire
Immix Biopharma, Inc. to Present NXC-201 Abstract at ASH 67th Annual Meeting - Quiver Quantitative
NXC-201 Abstract: Immix Biopharma to Present at ASH 67th Annual Meeting in Orlando Dec 6-9, 2025 - Stock Titan
Why Immix Biopharma Inc. stock appeals to analysts2025 Historical Comparison & Reliable Volume Spike Alerts - newser.com
Measuring Immix Biopharma Inc.’s beta against major indicesAnalyst Downgrade & Reliable Price Action Trade Plans - newser.com
Immix Biopharma Inc. stock chart pattern explainedEntry Point & Verified Short-Term Plans - newser.com
Analyzing Immix Biopharma Inc. with multi timeframe chartsMarket Trend Review & Free Real-Time Volume Trigger Notifications - newser.com
Will breakout in Immix Biopharma Inc. lead to full recoveryMarket Activity Summary & Low Risk High Win Rate Stock Picks - newser.com
Immix Biopharma to Present at the 37th Annual Piper Sandler Healthcare Conference - The Manila Times
Immix Biopharma, Inc. to Host Investor Meetings at 37th Annual Piper Sandler Healthcare Conference - Quiver Quantitative
Clinical-Stage Cell Therapy Developer ImmixBio to Showcase AL Amyloidosis Pipeline at Major Healthcare Conference - Stock Titan
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):